Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» HER2-positive metastatic breast cancer
HER2-positive metastatic breast cancer
Dizal reports positive Phase I data for breast cancer therapy
Clinical Trials Arena
Tue, 09/6/22 - 10:37 am
Dizal Pharmaceutical
clinical trials
breast cancer
HER2-positive metastatic breast cancer
DZD1516
May 15 ASCO Quick Takes: After-hours pop for Iovance, MacroGenics; plus Takeda, Amgen, Forty Seven
BioCentury
Wed, 05/15/19 - 11:52 pm
Iovance
LN-145
cervical cancer
Takeda
TAK-788
non-small cell lung cancer
Amgen
AMG-510
Macrogenics
margetuximab
HER2-positive metastatic breast cancer
Forty Seven
FDA approves Celltrion's Herceptin biosimilar
BioCentury
Sun, 12/16/18 - 12:23 am
FDA
Herceptin
biosimilars
Celltrion
HER2-positive metastatic breast cancer
Chinese Biotech Bio-Thera Solutions Initiates Ph III Trial of HER2 ADC in Metastatic Breast Cancer
CP Wire
Thu, 11/1/18 - 10:29 am
Bio-Thera Solutions
HER2-positive metastatic breast cancer
BAT8001
China
Chinese Biotech Bio-Thera Solutions Initiates Ph III Trial of HER2 ADC in Metastatic Breast Cancer
Thu, 11/1/18 - 09:52 am
Bio-Thera Solutions
HER2-positive metastatic breast cancer
BAT8001
Seattle Genetics Announces Results of Two Ph II Trials of Tucatinib in HER2- Positive Metastatic Breast Cancer
CP Wire
Wed, 07/11/18 - 10:12 am
Seattle Genetics
tucatinib
orphan drugs
clinical trials
HER2-positive metastatic breast cancer
breast cancer
Seattle Genetics Announces Results of Two Ph II Trials of Tucatinib in HER2- Positive Metastatic Breast Cancer
Wed, 07/11/18 - 09:37 am
Seattle Genetics
tucatinib
breast cancer
HER2-positive metastatic breast cancer
Pfizer's Herceptin biosimilar succeeds in key breast cancer study
Yahoo/Reuters
Wed, 11/30/16 - 09:44 pm
Pfizer
biosimilars
Herceptin
PF-05280014
HER2-positive metastatic breast cancer
Oncothyreon Breast Cancer Drug Exits ASCO '15 With Good Buzz
TheStreet.com
Mon, 06/1/15 - 09:43 am
Oncothyreon
breast cancer
ASCO
ONT-380
HER2-positive metastatic breast cancer
Puma Biotechnology Announces Presentation of Positive PB272 Phase II Data at the 2014 ASCO Annual Meeting
Yahoo/BusinessWire
Sun, 06/1/14 - 11:33 am
Puma Biotechnology
PB272
breast cancer
HER2-positive metastatic breast cancer
NICE rejects Roche's hot new breast cancer drug Kadcyla, then invites negotiations
Fierce Pharma
Wed, 04/23/14 - 12:02 pm
breast cancer
Roche
NICE
Kadcyla
HER2-positive metastatic breast cancer
